Walleye Capital LLC Olema Pharmaceuticals, Inc. Call Options Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
Call Options
3 transactions
Others Institutions Holding OLMA
# of Institutions
161Shares Held
69.2MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$32.6 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$31.9 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$25 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$17.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$16 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $177M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...